Cargando…

Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes

Pneumonia represents a major health care burden and Gram‐negative bacteria provide an increasing therapeutic challenge at least in part through the emergence of multidrug‐resistant strains. IL‐33 is a multifunctional cytokine belonging to the IL‐1 family that can affect many different cell types. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramirez‐Moral, Ivan, Blok, Dana C, Bernink, Jochem H, Garcia‐Laorden, M Isabel, Florquin, Sandrine, Boon, Louis, van't Veer, Cornelis, Mack, Matthias, Saluzzo, Simona, Knapp, Sylvia, Spits, Hergen, de Vos, Alex F, van der Poll, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986604/
https://www.ncbi.nlm.nih.gov/pubmed/33305354
http://dx.doi.org/10.1002/path.5601
_version_ 1783668475090173952
author Ramirez‐Moral, Ivan
Blok, Dana C
Bernink, Jochem H
Garcia‐Laorden, M Isabel
Florquin, Sandrine
Boon, Louis
van't Veer, Cornelis
Mack, Matthias
Saluzzo, Simona
Knapp, Sylvia
Spits, Hergen
de Vos, Alex F
van der Poll, Tom
author_facet Ramirez‐Moral, Ivan
Blok, Dana C
Bernink, Jochem H
Garcia‐Laorden, M Isabel
Florquin, Sandrine
Boon, Louis
van't Veer, Cornelis
Mack, Matthias
Saluzzo, Simona
Knapp, Sylvia
Spits, Hergen
de Vos, Alex F
van der Poll, Tom
author_sort Ramirez‐Moral, Ivan
collection PubMed
description Pneumonia represents a major health care burden and Gram‐negative bacteria provide an increasing therapeutic challenge at least in part through the emergence of multidrug‐resistant strains. IL‐33 is a multifunctional cytokine belonging to the IL‐1 family that can affect many different cell types. We sought here to determine the effect of recombinant IL‐33 on the host response during murine pneumonia caused by the common Gram‐negative pathogen Klebsiella pneumoniae. IL‐33 pretreatment prolonged survival for more than 1 day during lethal airway infection and decreased bacterial loads at the primary site of infection and distant organs. Postponed treatment with IL‐33 (3 h) also reduced bacterial growth and dissemination. IL‐33‐mediated protection was not observed in mice deficient for the IL‐33 receptor component IL‐1 receptor‐like 1. IL‐33 induced a brisk type 2 response, characterized by recruitment of type 2 innate lymphoid cells to the lungs and enhanced release of IL‐5 and IL‐13. However, neither absence of innate lymphoid cells or IL‐13, nor blocking of IL‐5 impacted on IL‐33 effects in mice infected with Klebsiella. Likewise, IL‐33 remained effective in reducing bacterial loads in mice lacking B, T, and natural killer T cells. Experiments using antibody‐mediated cell depletion indicated that neutrophils and inflammatory monocytes were of importance for antibacterial defense. The capacity of IL‐33 to restrict bacterial growth in the lungs was strongly reduced in mice depleted of both neutrophils and inflammatory monocytes, but not in mice selectively depleted of either one of these cell types. These results suggest that IL‐33 boosts host defense during bacterial pneumonia by a combined effect on neutrophils and inflammatory monocytes. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.
format Online
Article
Text
id pubmed-7986604
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-79866042021-03-25 Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes Ramirez‐Moral, Ivan Blok, Dana C Bernink, Jochem H Garcia‐Laorden, M Isabel Florquin, Sandrine Boon, Louis van't Veer, Cornelis Mack, Matthias Saluzzo, Simona Knapp, Sylvia Spits, Hergen de Vos, Alex F van der Poll, Tom J Pathol Original Papers Pneumonia represents a major health care burden and Gram‐negative bacteria provide an increasing therapeutic challenge at least in part through the emergence of multidrug‐resistant strains. IL‐33 is a multifunctional cytokine belonging to the IL‐1 family that can affect many different cell types. We sought here to determine the effect of recombinant IL‐33 on the host response during murine pneumonia caused by the common Gram‐negative pathogen Klebsiella pneumoniae. IL‐33 pretreatment prolonged survival for more than 1 day during lethal airway infection and decreased bacterial loads at the primary site of infection and distant organs. Postponed treatment with IL‐33 (3 h) also reduced bacterial growth and dissemination. IL‐33‐mediated protection was not observed in mice deficient for the IL‐33 receptor component IL‐1 receptor‐like 1. IL‐33 induced a brisk type 2 response, characterized by recruitment of type 2 innate lymphoid cells to the lungs and enhanced release of IL‐5 and IL‐13. However, neither absence of innate lymphoid cells or IL‐13, nor blocking of IL‐5 impacted on IL‐33 effects in mice infected with Klebsiella. Likewise, IL‐33 remained effective in reducing bacterial loads in mice lacking B, T, and natural killer T cells. Experiments using antibody‐mediated cell depletion indicated that neutrophils and inflammatory monocytes were of importance for antibacterial defense. The capacity of IL‐33 to restrict bacterial growth in the lungs was strongly reduced in mice depleted of both neutrophils and inflammatory monocytes, but not in mice selectively depleted of either one of these cell types. These results suggest that IL‐33 boosts host defense during bacterial pneumonia by a combined effect on neutrophils and inflammatory monocytes. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. John Wiley & Sons, Ltd 2021-01-19 2021-04 /pmc/articles/PMC7986604/ /pubmed/33305354 http://dx.doi.org/10.1002/path.5601 Text en © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Papers
Ramirez‐Moral, Ivan
Blok, Dana C
Bernink, Jochem H
Garcia‐Laorden, M Isabel
Florquin, Sandrine
Boon, Louis
van't Veer, Cornelis
Mack, Matthias
Saluzzo, Simona
Knapp, Sylvia
Spits, Hergen
de Vos, Alex F
van der Poll, Tom
Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes
title Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes
title_full Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes
title_fullStr Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes
title_full_unstemmed Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes
title_short Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes
title_sort interleukin‐33 improves local immunity during gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986604/
https://www.ncbi.nlm.nih.gov/pubmed/33305354
http://dx.doi.org/10.1002/path.5601
work_keys_str_mv AT ramirezmoralivan interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes
AT blokdanac interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes
AT berninkjochemh interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes
AT garcialaordenmisabel interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes
AT florquinsandrine interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes
AT boonlouis interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes
AT vantveercornelis interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes
AT mackmatthias interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes
AT saluzzosimona interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes
AT knappsylvia interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes
AT spitshergen interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes
AT devosalexf interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes
AT vanderpolltom interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes